TickerFactsScreenerDevelopers

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2000: $02009: $1.0K2010: $93.0K2011: $1.92M2012: $1.32M2013: $3.50M2014: $4.25M2015: $428.0K2016: $547.0K2017: $2.48M2018: $942.0K2019: $536.0K2020: $37.83M2021: $18.86M2022: $772.0K2023: $1.30M2024: $187.0K2025: $29.0K$29.0K
2000Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$29.0K-84.5%
2024$187.0K-85.6%
2023$1.30M+68.4%
2022$772.0K-95.9%
2021$18.86M-50.2%
2020$37.83M+6957.6%
2019$536.0K-43.1%
2018$942.0K-62.1%
2017$2.48M+353.9%
2016$547.0K+27.8%
2015$428.0K-89.9%
2014$4.25M+21.4%
2013$3.50M+166.0%
2012$1.32M-31.5%
2011$1.92M+1967.7%
2010$93.0K+9200.0%
2009$1.0K—
2000$0—